2025 annual financial data
Ionis Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 16.06%.
Operating income was -382,000,000 USD and net income was -381,000,000 USD.
Operating cash flow was -268,583,000 USD.
Get free Ionis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 944,000,000 USD
- Operating income
- -382,000,000 USD
- Net income
- -381,000,000 USD
- Operating cash flow
- -268,583,000 USD